SCOUT INVESTMENTS, INC. - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SCOUT INVESTMENTS, INC. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$2,695,000
-90.0%
15,594
-93.4%
0.04%
-89.2%
Q4 2014$27,031,000
+234.0%
235,171
+354.0%
0.42%
+280.7%
Q3 2014$8,093,000
-16.6%
51,799
-34.1%
0.11%
-3.5%
Q2 2014$9,701,000
-0.2%
78,647
-16.2%
0.11%
+1.8%
Q1 2014$9,720,000
+6.6%
93,814
-7.5%
0.11%
+5.7%
Q4 2013$9,122,000
+29.9%
101,421
-3.5%
0.10%
+114.3%
Q3 2013$7,025,000
-2.4%
105,046
-3.4%
0.05%
-41.7%
Q2 2013$7,197,000108,7960.08%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders